December 1, 2025 · Form 4 insider transaction
Tressler Nick B. bought 150,000 shares of Vistagen Therapeutics, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
The stock options were granted in connection with the Reporting Person's appointment as Chief Financial Officer.; 25% of the stock options vest on June 23, 2026 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date.